Baltimore, Maryland
United States
27
2025-11-20
The entities that hold a legal rights for patent applications filed by inventor MacKerell, Jr. Alexander D.:
Alexander D. MacKerell, Jr. from Baltimore, US has applied for patents for these inventions. The list has both pending applications and granted patents:
INHIBITORS OF EXTRACELLULAR SIGNAL-REGULATED KINASE
#2 | 2025-04-24INHIBITORS OF EXTRACELLULAR SIGNAL-REGULATED KINASE
#3 | 2025-03-27NON-ATP/CATALYTIC SITE p38 MITOGEN ACTIVATED PROTEIN KINASE INHIBITORS
#4 | 2024-11-07NON-CATALYTIC SUBSTRATE-SELECTIVE p38alpha-SPECIFIC MAPK INHIBITORS WITH ENDOTHELIAL-STABILIZING AND ANTI-INFLAMMATORY ACTIVITY, AND METHODS OF USE THEREOF
#5 | 2024-04-25BROAD SPECTRUM ANTIVIRAL COMPOUNDS TARGETING THE SKI COMPLEX
#6 | 2023-10-05Non-ATP/catalytic site p38 mitogen activated protein kinase inhibitors
#7 | 2023-06-29Non-catalytic substrate-selective p38alpha-specific MAPK inhibitors with endothelial-stabilizing and anti-inflammatory activity, and methods of use thereof
#8 | 2022-10-20Non-catalytic substrate-selective p38α-specific MAPK inhibitors with endothelial-stabilizing and anti-inflammatory activity, and methods of use thereof
#9 | 2021-10-14Non-ATP/catalytic site p38 Mitogen Activated Protein Kinase inhibitors
#10 | 2021-09-02Non-catalytic substrate-selective, p38α-specific MAPK inhibitors with endothelial-stabilizing and anti-inflammatory activity, and methods of use thereof
#11 | 2020-10-22Non-ATP/catalytic site p38 mitogen activated protein kinase inhibitors
#12 | 2019-08-29RUNX2 transcription factor inhibitors and uses thereof
#13 | 2019-05-23NON-CATALYTIC SUBSTRATE-SELECTIVE P38alpha-SPECIFIC MAPK INHIBITORS WITH ENDOTHELIAL-STABILIZING AND ANTI-INFLAMMATORY ACTIVITY, AND METHODS OF USE THEREOF
#14 | 2018-12-27METHODS AND SYSTEMS FOR ORGANIC SOLUTE SAMPLING OF AQUEOUS AND HETEROGENEOUS ENVIRONMENTS
#15 | 2018-10-18METHOD FOR BINDING SITE IDENTIFICATION BY MOLECULAR DYNAMICS SIMULATION (SILCS: SITE IDENTIFICATION BY LIGAND COMPETITIVE SATURATION)
#16 | 2016-12-08METHODS AND SYSTEMS FOR ORGANIC SOLUTE SAMPLING OF AQUEOUS AND HETEROGENEOUS ENVIRONMENTS
#17 | 2016-03-10Method for binding site identification by molecular dynamics simulation (silcs: site identification by ligand competitive saturation)
#18 | 2015-12-17LRRK2 GTP binding inhibitors for treatment of Parkinson's disease and neuroinflammatory disorders
#19 | 2014-06-26Non-ATP dependent inhibitors of extracellular signal-regulated kinase (ERK)
#20 | 2013-12-12Defensin-like molecules as novel antimicrobial agents
#21 | 2013-09-05Defensin-like molecules as novel antimicrobial agents
#22 | 2012-03-01METHOD FOR BINDING SITE IDENTIFICATION BY MOLECULAR DYNAMICS SIMULATION (SILCS: SITE IDENTIFICATION BY LIGAND COMPETITIVE SATURATION)
#23 | 2011-10-20SHP-2 phosphatase inhibitor
#24 | 2011-07-14METHODS AND COMPOSITIONS OF TRAIL-DEATH RECEPTOR AGONISTS/ACTIVATORS
#25 | 2010-05-27Small molecule inhibitors of BCL6
#26 | 2009-12-03Inhibitors for Extracellular Signal-Regulated Kinase Docking Domains and Uses Therefor
#27 | 2008-09-04Methods and compositions of trail-death receptor agonists/activators
425620 ⎘